Lactulose
CAS No. 4618-18-2
Lactulose ( Lactulose; Cholac; Generlac; Consulose; BRN 0093773; BRN-0093773; BRN0093773 )
产品货号. M14557 CAS No. 4618-18-2
Lactulose is a non-absortable sugar used in the treatment of constipation and hepatic encephalopathy.
纯度: >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
50MG | ¥267 | 有现货 |
|
100MG | 获取报价 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Lactulose
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Lactulose is a non-absortable sugar used in the treatment of constipation and hepatic encephalopathy.
-
产品描述Lactulose is a non-absortable sugar used in the treatment of constipation and hepatic encephalopathy. It generally begin working after eight to twelve hours but may take up to two days to improve constipation.
-
同义词Lactulose; Cholac; Generlac; Consulose; BRN 0093773; BRN-0093773; BRN0093773
-
通路Others
-
靶点Other Targets
-
受体β-gal
-
研究领域Other Indications
-
适应症——
化学信息
-
CAS Number4618-18-2
-
分子量342.30
-
分子式C12H22O11
-
纯度>98%(HPLC)
-
溶解度Water: 68 mg/mL (198.65 mM); DMSO: 68 mg/mL (198.65 mM)
-
SMILESOCC1([C@H]([C@@H]([C@@H](CO)O1)O[C@H]2[C@@H]([C@H]([C@H]([C@@H](CO)O2)O)O)O)O)O
-
化学全称(2S,3R,4S,5R,6R)-2-(((2R,3S,4S)-4,5-dihydroxy-2,5-bis(hydroxymethyl)tetrahydrofuran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Algieri F, et al. J Agric Food Chem. 2014 May 14; 62(19):4285-97.
产品手册
关联产品
-
Azido-PEG1-CH2CO2H
Azido-PEG1-CH2CO2H is a PROTAC linker that refers to an alkyl/ether combination. Azido-PEG1-CH2CO2H can be used to synthesize PROTAC BRD4 Degrader-1.
-
2,6-Dimethylbenzoqui...
2, 6-Dimethoxybenzoquinone (2, 6-DMBQ) is a benzoquinone, a chemical compound found in Rauvolfia vomitoria and in Tibouchina pulchra.
-
CP-24879 hydrochlori...
CP-24879 hydrochloride, a Δ5D/Δ6D dual-inhibitor, can significantly reduce intracellular lipid accumulation and inflammatory injury in hepatocytes. CP-24879 hydrochloride exhibits superior antisteatotic and anti-inflammatory actions in fat-1 and ω-3-treated hepatocytes.